Overview

The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .

Status:
COMPLETED

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is - Comparison of Empagliflozin - Linagliptin with Empagliflozin - Metformin combination therapy in reduction of body weight in T2DM Patients and it included 200 diabetic subjects with total study period of 12 weeks and individual study period of 4 weeks .

Phase:

PHASE4

Details

Lead Sponsor:

Bahria University

Treatments:

empagliflozin
Linagliptin
Metformin